Global Information
회사소개 | 문의 | 비교리스트

세계의 가상 임상시험 시장 분석(2022년)

Virtual Clinical Trials Global Market Report 2022

리서치사 The Business Research Company
발행일 2022년 07월 상품코드 1107237
페이지 정보 영문 175 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 4,000 ₩ 5,268,000 PDF (Single User License)
US $ 6,000 ₩ 7,902,000 PDF (Site License)
US $ 8,000 ₩ 10,536,000 PDF (Enterprise License)


세계의 가상 임상시험 시장 분석(2022년) Virtual Clinical Trials Global Market Report 2022
발행일 : 2022년 07월 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 가상 임상시험 시장은 2021년 88억 5,000만 달러에서 8.68%의 CAGR로 성장했으며, 2022년 96억 1,000만 달러로 확대될 것으로 예측됩니다. 가상 임상시험 시장은 7.75%의 CAGR로 성장하여 2026년 129억 6,000만 달러에 달할 것으로 예측됩니다.

2021년 가상 임상시험 시장에서는 북미가 가장 큰 지역이 되었습니다. 아시아태평양은 예측 기간 동안 가장 성장하는 지역으로 예상됩니다.

정부와 제약회사의 새로운 백신과 신약 개발을 위한 연구개발 투자 증가가 가상 임상시험 시장 성장을 촉진하고 있습니다. 의료 산업의 R&D 부서는 의약품 및 제품 품질 보증 및 임상 데이터 관리를 강화하기 위해 가상 임상시험 솔루션 및 서비스를 활용하기 위해 노력하고 있습니다.

기술 진보는 가상 임상시험(Virtual Clinical Trials) 시장이 인기를 얻고 있는 주요 요인입니다. 가상 임상시험 시장에서 사업을 전개하는 주요 기업은 급성장하는 업계 수요에 대응하고 시장 입지를 강화하기 위해 고급 기술 솔루션 제공에 주력하고 있습니다.

목차

제1장 주요 요약

제2장 가상 임상시험 시장 특징

제3장 가상 임상시험 시장 경향과 전략

제4장 가상 임상시험 : 신종 코로나 바이러스 감염(COVID-19) 영향

제5장 가상 임상시험 시장 : 시장 규모·성장률

  • 과거 시장(금액, 2016-2021년)
    • 시장 촉진 요인
    • 시장 억제 요인
  • 시장 예측(금액, 2021-2026년, 2031년)
    • 시장 촉진 요인
    • 시장 억제 요인

제6장 가상 임상시험 시장 내역

  • 설계별 시장 구분(금액, 2016-2021년, 2021-2026년, 2031년)
    • 관찰 시험
    • 개입 시험
    • 확장 참가 시험
  • 위상별 시장 구분(금액, 2016-2021년, 2021-2026년, 2031년)
    • 페이즈 I
    • 페이즈 II
    • 페이즈 III
    • 단계 IV
  • 적응증별 시장 구분(금액, 2016-2021년, 2021-2026년, 2031년)
    • CNS(중추신경계)
    • 자가면역질환/염증
    • 순환기
    • 대사·내분비 질환
    • 감염증
    • 종양
    • 비뇨 생식기
    • 안과
    • 기타

제7장 가상 임상시험 시장 : 지역별·국가별 분석

  • 지역별 시장 구분(금액, 2016-2021년, 2021-2026년, 2031년)
  • 국가별 시장 구분(금액, 2016-2021년, 2021-2026년, 2031년)

제8장 아시아태평양의 가상 임상시험 시장

  • 시장 개요
  • 지역 정보
  • 설계별 시장 구분(금액, 2016-2021년, 2021-2026년, 2031년)
  • 적응증별 시장 구분(금액, 2016-2021년, 2021-2026년, 2031년)

제9장 중국의 가상 임상시험 시장

제10장 인도의 가상 임상시험 시장

제11장 일본의 가상 임상시험 시장

제12장 호주의 가상 임상시험 시장

제13장 인도네시아의 가상 임상시험 시장

제14장 한국의 가상 임상시험 시장

제15장 서구의 가상 임상시험 시장

제16장 영국의 가상 임상시험 시장

제17장 독일의 가상 임상시험 시장

제18장 프랑스의 가상 임상시험 시장

제19장 동유럽의 가상 임상시험 시장

제20장 러시아의 가상 임상시험 시장

제21장 북미의 가상 임상시험 시장

제22장 미국의 가상 임상시험 시장

제23장 남미의 가상 임상시험 시장

제24장 브라질의 가상 임상시험 시장

제25장 중동의 가상 임상시험 시장

제26장 아프리카의 가상 임상시험 시장

제27장 가상 임상시험 : 경쟁 상황과 기업 프로필

  • 가상 임상시험 시장 : 경쟁 상황
  • 가상 임상시험 시장 : 기업 프로필
    • ICON, plc
    • Parexel International
    • IQVIA
    • Covance
    • PRA Health Sciences

제28장 가상 임상시험 시장의 주요 기업 합병 및 인수(M&A)

제29장 가상 임상시험 시장 : 미래 전망과 잠재 분석

제30장 부록

NJH 22.08.05

“Virtual Clinical Trials Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global virtual clinical trials market.

This report focuses on virtual clinical trials market which is experiencing strong growth. The report gives a guide to the virtual clinical trials market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the virtual clinical trials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Virtual Clinical Trials market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider virtual clinical trials market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The virtual clinical trials market section of the report gives context. It compares the virtual clinical trials market with other segments of the virtual clinical trials market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, virtual clinical trials indicators comparison.

Scope

Markets Covered:

  • 1) By Design: Observational Trials; Interventional Trials; Expanded Access Trials
  • 2) By Phases: Phase I; Phase II; Phase III; Phase IV
  • 3) By Indication: CNS; Autoimmune/Inflammation; Cardiovascular Disease; Metabolic/Endocrinology; Infectious Disease; Oncology; Genitourinary; Ophthalmology; Others
  • Companies Mentioned: ICON, plc; Parexel International; IQVIA; Covance; PRA Health Sciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

Major players in the virtual clinical trials market are: ICON, plc, Parexel International, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab, Medidata, Oracle Inc., CRF Health, Clinical Ink, Inc., Medable, Inc., Signant Health, Thread Research, Halo Health Systems, and Croprime.

The global virtual clinical trials market is expected to grow from $8.85 billion in 2021 to $9.61 billion in 2022 at a compound annual growth rate (CAGR) of 8.68%. The virtual clinical trials market is expected to grow to $12.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.75%.

The virtual clinical trials market consists of sales of virtual clinical trials solutions and related services by entities (organizations, sole traders, and partnerships) that refers to remote or decentralized clinical trials or studies that incorporate digital health technologies and enable remote participation outside the traditional brick-and-mortar clinical trial site using tablets, smartphone apps, or wearable sensors. Virtual clinical trials allow significant digital changes in clinical research methodology, resulting in a more patient-centric ecosystem. These solutions consider many technological advantages, including innovative applications, electronic devices, online social engagement platforms, artificial intelligence, robotic process automation, machine learning, and others.

The main design types of virtual clinical trials include observational trials, interventional trials, and expanded access trials. The observational trials refer to virtual clinical trials solutions and services used in the observational trials. Observational studies aim to learn what occurs to people in various contexts. The study team observes the participants but does not influence the therapies they get. The virtual clinical trials are used in Phase I, Phase II, Phase III, and Phase IV, and they are used in clinical trials of drugs are devices used in the treatment of CNS, autoimmune/inflammation, cardiovascular diseases, metabolic/endocrinology, infectious diseases, oncology, genitourinary, ophthalmology, and others.

North America was the largest region in the virtual clinical trials market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The virtual clinical trials market research report is one of a series of new reports from The Business Research Company that provides virtual clinical trials market statistics, including virtual clinical trials industry global market size, regional shares, competitors with a virtual clinical trials market share, detailed virtual clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the virtual clinical trials industry. This virtual clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increasing investments by the government and pharmaceutical companies in the R&D for the development of new vaccines and drugs are driving the growth of the virtual clinical trials market. The R&D divisions in the medical industry are increasingly utilizing virtual clinical trial solutions and services to increase quality assurance and clinical data management of drugs and their products. For instance, according to the study published in Research!America, a non-profit medical and health research advisory, the medical and health R&D investment in the USA was recorded at $241.5 billion in 2020 an 11.1% increase from 2019. Additionally, in June 2021, an article published by Mckinsey, COVID-19 pandemic, has catalyzed the adoption of decentralized clinical trials by pharma companies while highlighting the critical benefits of virtual trials and improving the patient and physician experience. Therefore, the increasing investments by the government and pharmaceutical companies in new vaccines and drug development are driving the growth of virtual clinical trials.

Technology advancement is a key trend gaining popularity in the virtual clinical trials market. Major companies operating in the virtual clinical trials market are focused on providing technologically-advanced solutions to meet fast-growing industry demands and strengthen their market position. These companies are implementing new generation virtual clinical technologies into their services, such as wearable technologies, mHealth, blockchain, cloud computing, EMR integration, actionable data, threshold monitoring, AI, SFTP, ETL services, and others. For instance, In April 2022, Unlearn.AI, a US-based startup, will launch a new digital twin RCTs technology for clinical trials that enables smaller control groups while maintaining power and generating evidence suitable for supporting regulatory decisions using AI and historical data.

In August 2019, Water Street Health Partners and JLL Partners, USA-based private equity companies acquired Thread for an undisclosed amount. Through this acquisition, the equity partners are focused on increasing the customer base and business operation of Thread across the globe. Thread is a North Carolina-based company involved in offering virtual clinical trial solutions and services.

The countries covered in the virtual clinical trials market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Table of Contents

1. Executive Summary

2. Virtual Clinical Trials Market Characteristics

3. Virtual Clinical Trials Market Trends And Strategies

4. Impact Of COVID-19 On Virtual Clinical Trials

5. Virtual Clinical Trials Market Size And Growth

  • 5.1. Global Virtual Clinical Trials Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Virtual Clinical Trials Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Virtual Clinical Trials Market Segmentation

  • 6.1. Global Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Observational Trials
  • Interventional Trials
  • Expanded Access Trials
  • 6.2. Global Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • 6.3. Global Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • CNS
  • Autoimmune/Inflammation
  • Cardiovascular Disease
  • Metabolic/Endocrinology
  • Infectious Disease
  • Oncology
  • Genitourinary
  • Ophthalmology
  • Others

7. Virtual Clinical Trials Market Regional And Country Analysis

  • 7.1. Global Virtual Clinical Trials Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Virtual Clinical Trials Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Virtual Clinical Trials Market

  • 8.1. Asia-Pacific Virtual Clinical Trials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Virtual Clinical Trials Market

  • 9.1. China Virtual Clinical Trials Market Overview
  • 9.2. China Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Virtual Clinical Trials Market

  • 10.1. India Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Virtual Clinical Trials Market

  • 11.1. Japan Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Virtual Clinical Trials Market

  • 12.1. Australia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Virtual Clinical Trials Market

  • 13.1. Indonesia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Virtual Clinical Trials Market

  • 14.1. South Korea Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Virtual Clinical Trials Market

  • 15.1. Western Europe Virtual Clinical Trials Market Overview
  • 15.2. Western Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Virtual Clinical Trials Market

  • 16.1. UK Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Virtual Clinical Trials Market

  • 17.1. Germany Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Virtual Clinical Trials Market

  • 18.1. France Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.2. France Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Virtual Clinical Trials Market

  • 19.1. Eastern Europe Virtual Clinical Trials Market Overview
  • 19.2. Eastern Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Virtual Clinical Trials Market

  • 20.1. Russia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Virtual Clinical Trials Market

  • 21.1. North America Virtual Clinical Trials Market Overview
  • 21.2. North America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Virtual Clinical Trials Market

  • 22.1. USA Virtual Clinical Trials Market Overview
  • 22.2. USA Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Virtual Clinical Trials Market

  • 23.1. South America Virtual Clinical Trials Market Overview
  • 23.2. South America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Virtual Clinical Trials Market

  • 24.1. Brazil Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Virtual Clinical Trials Market

  • 25.1. Middle East Virtual Clinical Trials Market Overview
  • 25.2. Middle East Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Virtual Clinical Trials Market

  • 26.1. Africa Virtual Clinical Trials Market Overview
  • 26.2. Africa Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Virtual Clinical Trials Market Competitive Landscape And Company Profiles

  • 27.1. Virtual Clinical Trials Market Competitive Landscape
  • 27.2. Virtual Clinical Trials Market Company Profiles
    • 27.2.1. ICON, plc
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Parexel International
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. IQVIA
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Covance
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. PRA Health Sciences
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Virtual Clinical Trials Market

29. Virtual Clinical Trials Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q